MedTrace Logo

Evaluation of the Safety and Efficacy of Dehydrated Human Placenta Tissue (dHPT) for Wound Healing

NCT07375160 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-08-27

No results posted yet for this study

Summary

The retrospective trial is observational, intended to stand alone, complement and integrate data collected in ongoing clinical studies to aid in establishing payor coverage in the United States (U.S.) for Cellution Biologics allograft products with real-world evidence to support the clinical adoption in patients to manage chronic or surgical wounds.

Conditions

  • Diabetic Foot Ulcer (DFU)
  • Venous Leg Ulcer (VLU)
  • Pressure Ulcer (PU)

Interventions

BIOLOGICAL

dHPT, AIC

Sterile dehydrated Human Amnion - Intermediate Layer - Chorion Membrane Allograft

Sponsors & Collaborators

  • Cellution Biologics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-12
Primary Completion
2026-10-30
Completion
2026-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07375160 on ClinicalTrials.gov